Adaptation of baculovirus system for large-scale production of rAAV vector serotypes

被引：0
|
作者：
Kohlbrenner, E
Aslanidi, G
Knop, DR
Gorbatyuk, O
Nash, K
Mandel, RJ
Muzyczka, N
Burns, BJ
Snyder, RO
Zolotukhin, S
机构：
[1] Univ Florida, Powell Gene Therapy Ctr, MGM, Gainesville, FL USA
[2] Appl Genet Technol Corp, Alachua, FL USA
来源：
MOLECULAR THERAPY | 2004年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
420
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [1] Enabling large-scale manufacturing of rAAV vectors with the baculovirus/Sf9 production system
    Horowitz, E.
    Kells, A.
    Zhou, P.
    Goulet, M.
    Mazzarelli, A.
    Zhou, X.
    Wu, H.
    Hadaczek, P.
    Ciesielska, A.
    Bankiewicz, K.
    Nonnenmacher, M.
    Shu, Y.
    Carter, T.
    Cecchini, S.
    Scheel, M.
    Dismuke, D.
    HUMAN GENE THERAPY, 2017, 28 (12) : A105 - A105
  • [2] Large-scale production of pharmaceutical proteins using the baculovirus expression vector system (BEVS).
    Persson, B
    Hansen, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U292 - U292
  • [3] Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system
    Negrete, Alejandro
    Yang, Linda C.
    Mendez, Andres F.
    Levy, Justin R.
    Kotin, Robert M.
    JOURNAL OF GENE MEDICINE, 2007, 9 (11): : 938 - 948
  • [4] Large-scale optimisation and production of rAAV vector encoding VEGF in iCELLis bioreactors
    Galibert, L.
    Leinonen, H.
    Oruetxebarria, I.
    Toivanen, P.
    Turkki, V.
    Valkama, A.
    Hynynen, H.
    Laaksonen, I.
    Karna, R.
    Malinen, J.
    Peltola, S.
    Kotoneva, S.
    Vaisto, S.
    Vandamme, C.
    Kailaanmaki, A.
    Yla-Herttuala, S.
    Lesch, H.
    Lipponen, E.
    HUMAN GENE THERAPY, 2018, 29 (12) : A162 - A163
  • [5] Large-scale production of rotavirus VLP as vaccine candidate using Baculovirus Expression Vector System (BEVS)
    Park, JY
    Kim, H
    Hwang, HK
    Lee, SJ
    Kim, HS
    Hur, BK
    Ryu, YW
    An, CN
    Kim, JS
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2004, 14 (01) : 35 - 40
  • [6] The Impact of rAAV Genome Size on Vector Production in the Sf9-Baculovirus System
    Yang, Zhaohui
    Tjoanda, Clarissa
    Wang, XuShan
    Ahuja, Shreya
    Zhuang, Brandon
    Pla, Andrew
    Ng, Mary
    Nasta, Nicole
    Cheng, Jessica
    Nelson, Stuart
    Daniels, Garrett
    MOLECULAR THERAPY, 2024, 32 (04) : 246 - 246
  • [7] An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes
    W Kang
    L Wang
    H Harrell
    J Liu
    D L Thomas
    T L Mayfield
    M M Scotti
    G J Ye
    G Veres
    D R Knop
    Gene Therapy, 2009, 16 : 229 - 239
  • [8] An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes
    Kang, W.
    Wang, L.
    Harrell, H.
    Liu, J.
    Thomas, D. L.
    Mayfield, T. L.
    Scotti, M. M.
    Ye, G. J.
    Veres, G.
    Knop, D. R.
    GENE THERAPY, 2009, 16 (02) : 229 - 239
  • [9] Large-scale production of functional recombinant CAR in a baculovirus-insect cell system
    Zhou, M.
    Shi, B.
    Wang, P.
    Gu, J.
    Li, Z.
    ACTA VIROLOGICA, 2011, 55 (02) : 93 - 99
  • [10] Generation and Characterization of Stable Recombinant Baculoviruses for large-scale production of rAAV
    van Tongeren, H. M.
    Visser, R. N.
    van Meerendonk, M.
    Brandjes, A.
    Coolen, A. Gal
    Willems, J.
    Puri, P.
    Jaadar, H.
    McLure, C.
    Marsden, S. R.
    Deventer, S. Jh
    Sanders, B. P.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A104 - A104
12345